Kanso Diagnostics delivers affordable, lab-grade tests that are available anywhere, can be operated by anyone, and provide results in minutes. Kanso’s technology is the only solution that enables uncompromised, lab-grade results on the spot at a low price, thereby redefining the capabilities of molecular diagnostics. The first product addresses the critical need for rapid and accurate detection of sexually transmitted infections (STIs), including the detection of antimicrobial resistance (AMR). By empowering healthcare providers with accessible point-of-care testing, they can make swift, results-driven treatment decisions that improve patient care and outcomes. By shifting reimbursement from central labs to point-of-care providers in the US market, Kanso’s solution creates a new financial paradigm that rewards accessible, on-the-spot testing.